Global health care giant GlaxoSmithKline LLC (GSK) agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of Nel Giugno 2007 una meta-analisi scritta da Steve Nissen, a capo della divisione di medicina cardiovascolare all'ospedale di Cleveland, pubblicata nel New England Journal of Medicine , ha mostrato un aumento dell'odds ratio di infarto miocardico in pazienti sotto trattamento con rosiglitazone (Avandia). The combination of dutasteride and tamsulosin, sold under the brand names Combodart, Duodart, and Jalyn, is a medication produced by GlaxoSmithKline for the treatment of adult male symptomatic benign prostatic hyperplasia (BPH). GlaxoSmithKline (connu sous le sigle GSK) est une multinationale britannique, l'un des dix géants de l'industrie pharmaceutique mondiale. Elle résulte de la fusion entre Glaxo Wellcome et SmithKline Beecham en 2000. Our pharmaceuticals business discovers, develops and makes medicines to treat a broad range of the world's most common acute and chronic diseases. Die GlaxoSmithKline plc (GSK) ist ein britisches Pharmaunternehmen mit Hauptsitz in London. Das Unternehmen hat weitere Produktionsstätten in Europa sowie in Nordamerika und Asien. GlaxoSmithKline has agreed to pay $3 billion US in criminal and civil fines and plead guilty to misdemeanour criminal charges related to the sale and marketing of its. GlaxoSmithKline (GSK) es una empresa británica de productos farmacéuticos, productos de cuidado dental y de cuidado de la salud. GSK es el resultado de la fusión de Glaxo Wellcome y SmithKline Beecham. Insulin-Sensitizer (nach dem chemischen Grundgerüst, einem Thiazol-2,4-dion auch Thiazolidindione; nach der gemeinsamen Endung Glitazone) sind eine Gruppe von Wirkstoffen, die in der Therapie des Diabetes mellitus Typ 2 angewendet werden. GlaxoSmithKline plc (GSK) is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.